Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Intraductal papillary components in invasive ductal carcinoma of the pancreas are associated with long-term survival of patients.

Fukushima N, Sakamoto M, Mukai K, Kanai Y, Shimada K, Kosuge T, Hirohashi S.

Hum Pathol. 2001 Aug;32(8):834-41.

PMID:
11521228
2.

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, Barthet M, O'Toole D, Rufat P, Partensky C, Cuillerier E, Lévy P, Belghiti J, Ruszniewski P.

Gut. 2002 Nov;51(5):717-22.

3.

Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.

Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB.

Pancreas. 2008 Jan;36(1):50-5. doi: 10.1097/MPA.0b013e31812575df.

PMID:
18192881
4.

Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients.

Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS.

Cancer. 2002 Jan 1;94(1):62-77.

5.

Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.

Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N.

Ann Surg Oncol. 2007 Nov;14(11):3174-80. Epub 2007 Aug 12.

PMID:
17694416
6.

[Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].

Ridwelski K, Meyer F, Schmidt U, Lippert H.

Zentralbl Chir. 2005 Aug;130(4):353-61. German.

PMID:
16103961
7.

Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas.

Nakagohri T, Asano T, Kenmochi T, Urashima T, Ochiai T.

World J Surg. 2002 Sep;26(9):1166-9. Epub 2002 Jun 6.

PMID:
12045867
8.

Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.

Nara S, Shimada K, Kosuge T, Kanai Y, Hiraoka N.

Am J Surg Pathol. 2008 Feb;32(2):243-55. doi: 10.1097/PAS.0b013e3181484f1e.

PMID:
18223327
9.

Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.

Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, Sueda T.

J Surg Oncol. 2009 Jul 1;100(1):13-8. doi: 10.1002/jso.21290.

PMID:
19384908
10.

Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases.

Fukushima N, Mukai K, Sakamoto M, Hasebe T, Shimada K, Kosuge T, Kinoshita T, Hirohashi S.

Virchows Arch. 2001 Jul;439(1):6-13.

PMID:
11499841
11.

Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe?

Jang JY, Kim SW, Lee SE, Yang SH, Lee KU, Lee YJ, Kim SC, Han DJ, Choi DW, Choi SH, Heo JS, Cho BH, Yu HC, Yoon DS, Lee WJ, Lee HE, Kang GH, Lee JM.

Ann Surg Oncol. 2008 Jan;15(1):199-205. Epub 2007 Oct 2.

PMID:
17909912
12.

Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Chari ST, Yadav D, Smyrk TC, DiMagno EP, Miller LJ, Raimondo M, Clain JE, Norton IA, Pearson RK, Petersen BT, Wiersema MJ, Farnell MB, Sarr MG.

Gastroenterology. 2002 Nov;123(5):1500-7.

PMID:
12404225
13.

Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience.

Takai S, Satoi S, Toyokawa H, Yanagimoto H, Sugimoto N, Tsuji K, Araki H, Matsui Y, Imamura A, Kwon AH, Kamiyama Y.

Pancreas. 2003 Apr;26(3):243-9.

PMID:
12657950
14.

Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.

Hirono S, Tani M, Kawai M, Ina S, Nishioka R, Miyazawa M, Fujita Y, Uchiyama K, Yamaue H.

Arch Surg. 2009 Apr;144(4):345-9; discussion 349-50. doi: 10.1001/archsurg.2009.2.

PMID:
19380648
15.

Long-term survival after surgical resection for pancreatic cancer.

Yoshizawa K, Nagai H, Kurihara K, Sata N, Kawai T, Saito K.

Hepatogastroenterology. 2001 Jul-Aug;48(40):1153-6.

PMID:
11490822
16.

The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma.

Ueda S, Ogata S, Tsuda H, Kawarabayashi N, Kimura M, Sugiura Y, Tamai S, Matsubara O, Hatsuse K, Mochizuki H.

Pancreas. 2004 Jul;29(1):e1-8.

PMID:
15211117
17.

Clinical significance of combined pancreas and portal vein resection in surgery for pancreatic adenocarcinoma.

Aramaki M, Matsumoto T, Etoh T, Ishio T, Himeno Y, Sasaki A, Yada K, Kawano K, Kitano S.

Hepatogastroenterology. 2003 Jan-Feb;50(49):263-6.

PMID:
12630036
18.

Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type.

Sadakari Y, Ohuchida K, Nakata K, Ohtsuka T, Aishima S, Takahata S, Nakamura M, Mizumoto K, Tanaka M.

Surgery. 2010 Jun;147(6):812-7. doi: 10.1016/j.surg.2009.11.011. Epub 2010 Jan 8.

PMID:
20060146
19.

Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome.

D'Angelica M, Brennan MF, Suriawinata AA, Klimstra D, Conlon KC.

Ann Surg. 2004 Mar;239(3):400-8.

20.

Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.

Salvia R, Fernández-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, Pederzoli P, Warshaw AL.

Ann Surg. 2004 May;239(5):678-85; discussion 685-7.

Supplemental Content

Support Center